Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 156 publications
Heterologous prime-boost immunization combining parenteral and mucosal routes with different adjuvants mounts long-lived CD4+ T cell responses in lungs.
Journal: Frontiers in immunology
Published: March 25, 2025
Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial.
Journal: The Lancet. Infectious diseases
Published: August 05, 2024
Author Correction: Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice.
Journal: Communications biology
Published: May 29, 2024
Human antibody signatures towards the Chlamydia trachomatis major outer membrane protein after natural infection and vaccination.
Journal: EBioMedicine
Published: December 15, 2023
Safety and Immunogenicity of the H56:IC31 Tuberculosis Vaccine Candidate in Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis: A Phase 1 Randomized Trial.
Journal: The Journal of infectious diseases
Published: November 14, 2023
An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial.
Journal: The Lancet. Infectious diseases
Published: November 13, 2023
C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates.
Journal: Frontiers in immunology
Published: January 31, 2023
Pulmonary Administration of the Liposome-Based Adjuvant CAF01: Effect of Surface Charge on Mucosal Adjuvant Function.
Journal: Molecular pharmaceutics
Published: December 30, 2022
Multi-component prime-boost Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model.
Journal: Frontiers in immunology
Published: September 29, 2022
Publisher Correction: A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars.
Journal: NPJ vaccines
Published: August 30, 2022
Monocytes Elicit a Neutrophil-Independent Th1/Th17 Response Upon Immunization With a Mincle-Dependent Glycolipid Adjuvant.
Journal: Frontiers in immunology
Published: February 21, 2022
Last Updated: 09/26/2026